On January 30, 2015, Peak Pharmaceuticals, Inc. entered into an employment agreement with Soren Mogelsvang regarding Mr. Mogelsvang's employment with the company as its President and Chief Executive Officer. The Employment Agreement is for a three year period from February 1, 2015 through January 31, 2018.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | 0.00% | 0.00% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+13.55% | 3,174B | |
+13.86% | 89.44B | |
+8.19% | 80.2B | |
-11.72% | 55.78B | |
+20.68% | 46.14B | |
+28.56% | 45.25B | |
-26.77% | 45.34B | |
+77.11% | 41.2B | |
-5.36% | 26.11B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals Appoints Soren Mogelsvang as President and Chief Executive Officer